Results 1 to 10 of about 578,843 (73)
Aim. To study the effectiveness of exogenous phosphocreatine (EPCr) therapy in patients with heart failure (HF) with reduced and mildly reduce dejection fraction (EF).Material and methods.
S. N. Tereshchenko +2 more
doaj +1 more source
Aim. To study the efficacy and safety of exogenous phosphocreatine (EF) in patients with chronic heart failure (CHF). Materials and methods. The all-Russian prospective observational study BYHEART included 842 patients who were treated with EF. Before
Sergey N. Tereshchenko +2 more
doaj +1 more source
Aim. To study the effectiveness of exogenous phosphocreatine (EP) therapy in patients with heart failure (HF) with reduced and mildly reduced ejection fraction (EF) receiving sacubitril/valsartan.Material and methods.
S. N. Tereshchenko, A. A. Safiullina
doaj +1 more source
Some of the next articles are maybe not open access.
Biotechnological Potential and Applications of Microbial Consortia
Biotechnology Advances, 2020Fengxue Xin +2 more
exaly
What Makes a Drug Discovery Consortium Successful?
Nature Reviews Drug Discovery, 2020Peter Simpson
exaly

